Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Its low valuation, with P/E ratio at 2.02 and 7.15 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company has a low valuation given the cash flows generated by its activity.

● The company is one of the best yield companies with high dividend expectations.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● Most analysts recommend that the stock should be sold or reduced.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.